Teva Branded Pharmaceutical Products R&d Llc

This Phase 3 trial tests whether a daily inhaler combining fluticasone (an anti-inflammatory steroid) and albuterol (a quick-relief bronchodilator) can prevent severe asthma attacks better than albuterol alone. About 2,772 adults with asthma who have had at least one severe attac…

This study tests an injectable drug called TEV-53408 in 50 adults with celiac disease who follow a gluten-free diet. Participants will be exposed to small amounts of gluten to see if the drug can prevent intestinal damage. The trial is placebo-controlled and lasts about 86 weeks,…

This early-stage trial tests a new drug called TEV-53408 in 38 adults with vitiligo. The main goal is to see if the drug is safe when given as a shot under the skin. Researchers will also look for early signs that it might help bring back skin color. The study lasts 84 weeks, inc…

This study tests two different doses of TEV-48574 (duvakitug) given as a shot every 4 weeks to adults with moderate to severe ulcerative colitis or Crohn's disease. Participants who completed a previous 14-week study can join. The goal is to see if the drug can keep the disease u…

This study aimed to test a new drug called TAK-573, given with steroids and other cancer drugs, for people with multiple myeloma that came back or didn't respond to treatment. The goal was to find a safe dose and see if it helps shrink tumors. However, the trial was withdrawn bef…